- gsearch

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov

Advanced Search

- gsearch

Search Results

Narrow Results:

2024 2
2022 6
2021 21
2020 2
2014 1

Centers for Disease Control and Prevention (U.S) 1
National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. 6
National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. 25
United States. Department of Homeland Security. Cybersecurity and Infrastructure Security Agency‏. 1

United States 1

Guidance 6
Press Release 1

1 - 20 of 32 Results

Refine Results

All Collections

Refine Results:

All Collections

Previous

1 2

Frequently asked questions about coronavirus (COVID-19) for laboratories

CITE Title : Frequently asked questions about coronavirus (COVID-19) for laboratories Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Oct. 25, 2021 URL : https://stacks.cdc.gov/view/cdc/111102 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Frequently asked questions about coronavirus (COVID-19) for laboratories. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Oct. 25, 2021

No Description
Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

CITE Title : Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Oct. 28, 2021 URL : https://stacks.cdc.gov/view/cdc/111111 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Oct. 28, 2021

:

Updated Oct. 28, 2021
Frequently asked questions about coronavirus (COVID-19) for laboratories

CITE Title : Frequently asked questions about coronavirus (COVID-19) for laboratories Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : 03/10/2021 URL : https://stacks.cdc.gov/view/cdc/104168 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Frequently asked questions about coronavirus (COVID-19) for laboratories. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

03/10/2021

:

Updated Mar. 10, 2021
Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)

CITE Title : Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Feb 26, 2021 URL : https://stacks.cdc.gov/view/cdc/104491 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Feb 26, 2021

:

Updated Feb. 26, 2021• The type of specimen collected when testing for current or past infection with SARS-CoV-2 is based on the test being performe...
Frequently asked questions about coronavirus (COVID-19) for laboratories

CITE Title : Frequently asked questions about coronavirus (COVID-19) for laboratories Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Aug. 15, 2020 URL : https://stacks.cdc.gov/view/cdc/92020 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Frequently asked questions about coronavirus (COVID-19) for laboratories. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Aug. 15, 2020

:

Updated Aug. 15, 2020
Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)

CITE Title : Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.;United States. Department of Homeland Security. Cybersecurity and Infrastructure Security Agency‏.; Published Date : November 3, 2020 Pages in Document : https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html Source : Coronavirus Disease 2020 (COVID-19) URL : https://stacks.cdc.gov/view/cdc/96863 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. ...

November 3, 2020 | Coronavirus Disease 2020 (COVID-19)

:

Updated Nov. 3, 2020Summary of Recent ChangesRevisions were made on November 3, 2020 to reflect the following:• Clarification on language for the co...
Frequently asked questions about coronavirus (COVID-19) for laboratories

CITE Title : Frequently asked questions about coronavirus (COVID-19) for laboratories Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Jan. 26, 2021 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/101294 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Frequently asked questions about coronavirus (COVID-19) for laboratories. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Jan. 26, 2021 | Coronavirus Disease 2019 (CoVID-19)

:

Updated Jan. 26, 2021
Cómo recoger una muestra del cornete nasal medio para una prueba de COVID-19

CITE Title : Cómo recoger una muestra del cornete nasal medio para una prueba de COVID-19 Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Apr 22, 2021 Pages in Document : 1 poster URL : https://stacks.cdc.gov/view/cdc/113955 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Cómo recoger una muestra del cornete nasal medio para una prueba de COVID-19. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Cómo recoger una muestra del cornete nasal medio para una prueba de COVID-19" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Cómo recoger una muestra del cornete nasal medio para una prueba de COVID-19" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Apr 22, 2021

:

How to collect a nasal mid-turbinate specimen for COVID-19 testing [Spanish]Use solamente un kit de recolección de muestras autorizado. Obtenga un ki...
How to collect a nasal mid-turbinate specimen for COVID-19 testing

CITE Title : How to collect a nasal mid-turbinate specimen for COVID-19 testing Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : June 15, 2021 Pages in Document : 1 poster URL : https://stacks.cdc.gov/view/cdc/113956 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). How to collect a nasal mid-turbinate specimen for COVID-19 testing. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "How to collect a nasal mid-turbinate specimen for COVID-19 testing" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "How to collect a nasal mid-turbinate specimen for COVID-19 testing" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

June 15, 2021

:

Use only an authorized specimen collection kit. Get a kit from your healthcare provider or a testing center. Kits are available at a pharmacy or other...
Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing

CITE Title : Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : May 18, 2022 URL : https://stacks.cdc.gov/view/cdc/117464 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2022). Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing" (2022) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing" , 2022 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

May 18, 2022

:

Updated May 18, 2022
Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing

CITE Title : Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : July 15, 2022 URL : https://stacks.cdc.gov/view/cdc/119427 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2022). Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing" (2022) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting and handling of clinical specimens for COVID-19 testing" , 2022 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

July 15, 2022

:

Updated July 15, 2022
v-safe COVID-19 vaccine pregnancy registry

CITE Title : v-safe COVID-19 vaccine pregnancy registry Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : May 3 2021 URL : https://stacks.cdc.gov/view/cdc/105813 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). v-safe COVID-19 vaccine pregnancy registry. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "v-safe COVID-19 vaccine pregnancy registry" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "v-safe COVID-19 vaccine pregnancy registry" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

May 3 2021

:

Updated May 3, 2021If you are pregnant, you might choose to be vaccinated when it’s available to you. There is currently no evidence that antibodies...
v-safe COVID-19 vaccine pregnancy registry

CITE Title : v-safe COVID-19 vaccine pregnancy registry Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Apr 20 2021 URL : https://stacks.cdc.gov/view/cdc/105314 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). v-safe COVID-19 vaccine pregnancy registry. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "v-safe COVID-19 vaccine pregnancy registry" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "v-safe COVID-19 vaccine pregnancy registry" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Apr 20 2021

:

Updated Apr. 20, 2021If you are pregnant, you might choose to be vaccinated when it’s available to you. There is currently no evidence that antibodi...
v-safe COVID-19 vaccine pregnancy registry

CITE Title : v-safe COVID-19 vaccine pregnancy registry Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Apr 27 2021 URL : https://stacks.cdc.gov/view/cdc/105519 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). v-safe COVID-19 vaccine pregnancy registry. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "v-safe COVID-19 vaccine pregnancy registry" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "v-safe COVID-19 vaccine pregnancy registry" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Apr 27 2021

:

Updated Apr. 27, 2021If you are pregnant, you might choose to be vaccinated when it’s available to you. There is currently no evidence that antibodi...
v-safe COVID-19 vaccine pregnancy registry

CITE Title : v-safe COVID-19 vaccine pregnancy registry Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Apr 6, 2021 URL : https://stacks.cdc.gov/view/cdc/104847 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). v-safe COVID-19 vaccine pregnancy registry. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "v-safe COVID-19 vaccine pregnancy registry" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "v-safe COVID-19 vaccine pregnancy registry" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Apr 6, 2021

:

Updated Apr. 6, 2021If you are pregnant, you might choose to be vaccinated when it’s available to you. There is currently no evidence that antibodie...
Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

CITE Title : Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : June 11, 2021 URL : https://stacks.cdc.gov/view/cdc/107046 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

June 11, 2021

:

Updated June 11, 2021All clinical specimens may contain potentially infectious materials. Precautions should be taken when handling specimens suspecte...
Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

CITE Title : Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : June 3, 2021 URL : https://stacks.cdc.gov/view/cdc/106807 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

June 3, 2021

:

Updated June 3, 2021All clinical specimens may contain potentially infectious materials. Precautions should be taken when handling specimens suspected...
v-safe COVID-19 vaccine pregnancy registry

CITE Title : v-safe COVID-19 vaccine pregnancy registry Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : June 7, 2021 URL : https://stacks.cdc.gov/view/cdc/106923 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). v-safe COVID-19 vaccine pregnancy registry. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "v-safe COVID-19 vaccine pregnancy registry" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "v-safe COVID-19 vaccine pregnancy registry" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

June 7, 2021

:

Updated June 7, 2021If you are pregnant, you might choose to be vaccinated when it’s available to you. There is currently no evidence that antibodie...
v-safe COVID-19 vaccine pregnancy registry

CITE Title : v-safe COVID-19 vaccine pregnancy registry Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : June 2, 2021 URL : https://stacks.cdc.gov/view/cdc/106734 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). v-safe COVID-19 vaccine pregnancy registry. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "v-safe COVID-19 vaccine pregnancy registry" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "v-safe COVID-19 vaccine pregnancy registry" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

June 2, 2021

:

Updated June 2, 2021If you are pregnant, you might choose to be vaccinated when it’s available to you. There is currently no evidence that antibodie...
Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

CITE Title : Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : May 12, 2021 URL : https://stacks.cdc.gov/view/cdc/106537 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

May 12, 2021

:

Updated May 12, 2021All clinical specimens may contain potentially infectious materials. Precautions should be taken when handling specimens suspected...

1 - 20 / 32

Previous

1 2